1. Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes. Issue 3 (30th January 2018) Authors: Williams, David S; Mouradov, Dmitri; Jorissen, Robert N; Newman, Marsali R; Amini, Elham; Nickless, David K; Teague, Julie A; Fang, Catherine G; Palmieri, Michelle; Parsons, Marie J; Sakthianandeswaren, Anuratha; Li, Shan; Ward, Robyn L; Hawkins, Nicholas J; Faragher, Ian; Jones, Ian T; Gibbs, Pe... Journal: Gut Issue: Volume 68:Issue 3(2019) Page Start: 465 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series. (September 2018) Authors: Domingo, Enric; Camps, Carme; Kaisaki, Pamela J; Parsons, Marie J; Mouradov, Dmitri; Pentony, Melissa M; Makino, Seiko; Palmieri, Michelle; Ward, Robyn L; Hawkins, Nicholas J; Gibbs, Peter; Askautrud, Hanne; Oukrif, Dahmane; Wang, Haitao; Wood, Joe; Tomlinson, Evie; Bark, Yasmine; Kaur, Kulvinder... Journal: Lancet gastroenterology and hepatology Issue: Volume 3:Number 9(2018) Page Start: 635 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗